Star Mountain is a Proud Participant of the Annual Cycle for Survival Event for Rare Cancer Research in New York, NY
Star Mountain will be riding in the 2017 Cycle for Survival where 100% of proceeds go directly to Memorial Sloan Kettering Cancer Center to beat rare cancers
NEW YORK, NY, USA, February 10, 2017 / — On Saturday, February 11th, Star Mountain Capital, a specialized alternative asset manager focused exclusively on the U.S. lower middle-market and Star Mountain Charitable Foundation will be participating in the Annual 2017 Cycle for Survival event in support of rare cancer research. The event will begin promptly at 10:00am at the Equinox Rockefeller Center and 100% of every dollar raised will go directly to Memorial Sloan Kettering Cancer Center‘s cancer research.
About 50 percent of people with cancer have a rare cancer. Rare cancers include brain, pancreatic, ovarian, stomach, all types of pediatric cancers, and many others. Even though they account for about half of all cancer diagnoses when combined, research on many rare cancers is drastically underfunded, often leaving patients with limited or no treatment options. Memorial Sloan Kettering Cancer Center—the world’s oldest and largest private cancer center—is committed to changing that reality. Their significant contributions to new and better cancer treatments—including the rarest forms of the disease—benefit patients at Memorial Sloan Kettering Cancer Center and around the world.
With $30 million raised in 2016 and over $100 million raised since Cycle for Survival started, we’ve made incredible progress. However, the battle is not finished. While we no longer have room on our cycling team, there is still time to help Star Mountain Capital reach its fundraising goal by donating to our team page located here.
For all donors, Star Mountain will be sponsoring a post-event celebration, following the event. Please visit www.StarMountainCapital.com/events for more information.
About Cycle for Survival:
Cycle for Survival is a Non-Profit Organization dedicated to beat rare cancers.
Star Mountain Capital, LLC